Haohai Biotec (06826) Publishes Next Day Disclosure Return on Share Repurchase and Issued Capital
Bulletin Express
Mar 06
Shanghai Haohai Biological Technology Co., Ltd. announced a repurchase and cancellation of 0.58 million H shares, completed on March 6, 2026. The repurchased shares constituted approximately 0.2561% of the existing H shares before the event, at an average price of HKD26.27 per share. Following this cancellation, the number of H shares stands at 35.93 million.
According to the disclosure, A shares remain at 190.20 million (excluding 3.85 million treasury shares). Consequently, the total number of issued shares (excluding treasury shares) is adjusted from 226.71 million to 226.13 million. No other changes in issued shares or treasury shares were reported.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.